Armo Biosciences Email Format
Biotechnology ResearchCalifornia, United States0-1 Employees
Armo Biosciences operates in the biotechnology research sector with a focus on immunotherapies for cancer. The company develops therapies designed to engage the immune system to treat cancers and solid tumors. Its lead candidate, AM0010 (pegilodecakin), was launched for investigation in 2017 and has been studied in metastatic renal cell carcinoma. Based in Palo Alto, California, Armo Biosciences is a small biotechnology firm pursuing immuno-oncology programs. Its work centers on developing therapies that target cancers and solid tumors through immune-based mechanisms, reflecting its position within the biotechnology research industry.